Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Memantine: Phase III

NTII partner Merz + Co. GmbH & Co. (Frankfurt, Germany) said that Memantine significantly

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE